AAD 2022: Eli Lilly plugs Olumiant 52-week data as JAK inhibitor looks to fill out label with industry-first alopecia nod
AAD 2022: Eli Lilly plugs Olumiant 52-week data as JAK [...]
AAD 2022: Eli Lilly plugs Olumiant 52-week data as JAK [...]
Moderna weighs private market debut for COVID shot as federal [...]
Fierce Pharma Asia—Chinese biotech’s Pfizer trade secret suit; Lilly, Innovent’s [...]
After Supreme Court win, Merck prevails against 500 Fosamax cases: [...]
Sun Pharma forks over $485M to settle long-running legal battle [...]
Merck telegraphs closure of Pennsylvania antibiotics plant that employs 300 [...]
Novartis’ Sandoz, following Pfizer’s lead, launches 2nd carcinogen-related drug recall [...]
‘No small feat’: Albireo CEO talks biotech’s commercial transition amid [...]
Merck, building on Keytruda’s landmark biomarker nod, pressures GSK’s limited [...]
As rivals eye ‘unjustified royalties,’ Pfizer partner sues to defend [...]